503A vs 503B Pharmacies: What Telehealth Founders Actually Need to Know

If you spend a week around telehealth, you will hear "503A" and "503B" thrown around like everyone was born knowing them. Here is the founder-level version.

503A: patient-specific compounding

A 503A pharmacy is a state-licensed compounding pharmacy that prepares medications for a specific patient with a specific prescription. One patient, one script, one compounded preparation. They are regulated primarily by state boards of pharmacy, with FDA oversight of certain requirements. Most personalized telehealth prescriptions, individualized dosing and combinations, flow through 503A pharmacies.

503B: outsourcing facilities

A 503B outsourcing facility registers directly with the FDA, follows CGMP manufacturing standards (the same quality framework drug manufacturers use), and can produce larger batches not tied to an individual prescription in advance. Think of them as the industrial-scale end of compounding, often supplying clinics and health systems.

Why a brand owner should care

Reliability and continuity. Your patients experience your pharmacy partner as YOUR brand. Backorders, shipping delays, and quality issues land on your reviews, not the pharmacy's. Working through infrastructure with multiple established pharmacy relationships means a hiccup at one partner does not stop your business.

Compliance exposure. The FDA actively polices compounding claims and marketing. A brand that implies compounded medications are FDA-approved (they are not, compounding is a legal pathway, not an approval) invites enforcement. Your marketing language matters as much as your pharmacy's license.

Catalog flexibility. Different products and dose forms come from different types of partners. A serious telehealth catalog, weight management, hormones, peptides where legally available, ED, hair, usually means multiple pharmacy relationships managed behind one storefront.

The question to ask any launch partner

Do not ask "do you have a pharmacy." Ask: how many pharmacy relationships does the platform maintain, who manages those relationships after launch, and what happens to my patients if one partner has a supply issue? The founders who ask that question up front are the ones who never have to ask it in a crisis.